Register Login

ORIC PHARMACEUTICALS, INC. (ORIC)

Piscitelli Dominic 🟡 adjusted position in 77.0K shares (2 derivative) of Oric Pharmaceuticals, Inc. (ORIC) at $13.69 ($1.8M) Transaction Date: Aug 26, 2026 | Filing ID: 000006

Full text
Register to leave comments
  • News bot Aug. 28, 2026, 8:12 p.m.

    🔍 Piscitelli Dominic (Executive)

    Company: Oric Pharmaceuticals, Inc. (ORIC)

    Report Date: 2026-08-26

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 77,000
    • Total shares sold: 154,000

    Detailed Transactions and Holdings:

    • Acquired 52,000 shares of Common Stock at $4.36 per share (Direct)
      Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 121,828.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 25,000 shares of Common Stock at $6.0 per share (Direct)
      Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 146,828.00 | transaction_form_type: 4
    • Sold 77,000 shares of Common Stock at $13.6859 per share (Direct)
      Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 69,828.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 52,000 shares of Stock Option (right to buy) at $4.36 per share (Derivative)
      Date: 2026-08-26 | Code: M | Expires: 2032-07-19 | Exercise: 2025-07-20 | equity_swap_involved: 0 | shares_owned_after: 92,500.00 | transaction_form_type: 4
    • Sold 25,000 shares of Stock Option (right to buy) at $6.0 per share (Derivative)
      Date: 2026-08-26 | Code: M | Expires: 2033-01-31 | equity_swap_involved: 0 | shares_owned_after: 120,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
    • F2: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.
    • F3: 25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.

Search

News categories